Reference | Disorder (in order of reference) | Data type | Application |
---|---|---|---|
Single-view learning | |||
Koivu et al. (2018) [123] | Down’s Syndrome (DS) | NeuroImage | Disease risk assessment |
Tenev et al. (2014) [119], Chen et al. (2019) [118], Eslami et al. (2019) [120] | ADHD, ADHD, ASD | NeuroImage | Patient classification |
Wang & Avillach (2021) [130], Feng et al. (2018) [126], Liu et al. (2021) [129] | ASD, DS, ADHD | Multi-Omics, Behavior | Patient classification |
ASD | NeuroImage | Diagnosis | |
ASD, FXS | Clinical | Diagnosis | |
Stahl et al. (2012) [122] | Cerebral Palsy (CP) | Behavior | Diagnosis |
Ramaswami et al. (2020) [21] | ASD | Multi-Omics | Disease sub-typing |
Voineagu (2011) [157], Johnson et al. (2016) [158], Gupta et al. (2014) [22] | ASD, Neurodevelopmental disease, ASD | Multi-Omics | Biomarker discovery |
Liu et al. (2021) [129] | ADHD | Multi-Omics | Biomarker discovery |
Cogill et al. (2016) [125] | ASD | Multi-Omics | Gene prioritization |
Kimura et al. (2019) [159] | Williams syndrome | Multi-Omics | Cellular/molecular pathways |
Multi-view learning | |||
ADHD, ASD | NeuroImage | Patient classification | |
Jacobs et al. (2021) [165] | Multiple | NeuroImage, Behavior | Disease sub-typing |